Farther Finance Advisors’s Humacyte HUMA Stock Holding History

Farther Finance Advisors’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4	Sell	8 -1,540	-99%	-$985	﹤0.01%	6117
2026 Q2	$1.22K	Buy	1,548 +723	+88%	+$670	﹤0.01%	5315
2026 Q1	$488	Buy	825 +802	+3,487%	+$834	﹤0.01%	5277
2025 Q4	$22	Buy	+23	New	+$33	﹤0.01%	5391
2025 Q2	–	Sell	-6,125	Closed	-$9.13K	–	4569
2025 Q1	$9.13K	Buy	6,125 +5,995	+4,612%	+$22.5K	﹤0.01%	2788
2024 Q4	$657	Buy	+130	New	+$643	﹤0.01%	3377

Other funds holding HUMA

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

AWM

Act Wealth Management Plano, Texas $340M AUM 15.43% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

Farther Finance Advisors's HUMA Position: Q3 2026 in Review

Farther Finance Advisors reduced its Humacyte (HUMA) stake by 99% in Q3 2026, selling an estimated $985 and leaving 8 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #6117.

Farther Finance Advisors first reported a position in HUMA in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.13K in Q1 2025. 5 funds tracked by Wall St. Rank hold HUMA as of Q3 2026.

Farther Finance Advisors held 8 shares of Humacyte worth $4 as of Q3 2026.
Farther Finance Advisors sold 1,540 Humacyte shares in Q3 2026, an estimated $985.
Humacyte made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #6117 holding.
Farther Finance Advisors first reported a position in Humacyte in Q4 2024 and has held it in 6 quarters since.
Farther Finance Advisors's Humacyte position peaked at $9.13K in Q1 2025.
5 funds tracked by Wall St. Rank held Humacyte as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.